Mannose-Binding Lectin 2 (MBL2) combined genotypes deficiency is associated with susceptibility for Oral Lichen Planus.
Journal
Genetics and molecular biology
ISSN: 1415-4757
Titre abrégé: Genet Mol Biol
Pays: Brazil
ID NLM: 100883590
Informations de publication
Date de publication:
Historique:
received:
16
01
2018
accepted:
30
04
2018
pubmed:
23
2
2019
medline:
23
2
2019
entrez:
23
2
2019
Statut:
ppublish
Résumé
Oral Lichen Planus (OLP) is an oral inflammatory condition, mediated by host immune system reaction, presenting basal membrane damages with inflammatory lesions in the mouth and/or skin. In this study, the role of functional polymorphisms in the MBL2 gene, encoding for Mannose-Binding Protein C (MBP-C), a member of the innate immune response and an acute-phase protein able to activate the complement cascade, was investigated to assess a possible association with OLP susceptibility in Italian patients. Two variations at the promoter region (called H/L and X/Y) and three at the first exon (at codon 52, 54, and 57) of the MBL2 gene were analyzed in 69 OLP patients and 244 healthy controls from northeastern Italy. Considering the polymorphisms singularly, the MBL2 X allele and C/T genotype of the D allele (correlated with low MBP-C expression) were associated with susceptibility to develop OLP. Moreover, when taking into account MBL2 combined genotypes, more OLP patients were deficient MBP-C producers than not deficient, who were more represented among healthy controls. MBL2 combined genotypes, responsible for deficient MBP-C production, are associated with an increased risk of developing OLP.
Identifiants
pubmed: 30794720
pii: S1415-47572019005006102
doi: 10.1590/1678-4685-GMB-2018-0015
pmc: PMC6428121
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9-14Références
J Immunol. 1999 Nov 1;163(9):4953-9
pubmed: 10528199
Br J Oral Maxillofac Surg. 2000 Aug;38(4):370-7
pubmed: 10922170
Crit Rev Oral Biol Med. 2002;13(4):350-65
pubmed: 12191961
Mol Immunol. 2003 Nov;40(7):423-9
pubmed: 14568388
Skinmed. 2003 Nov-Dec;2(6):342-7; quiz 348-9
pubmed: 14673245
Croat Med J. 2006 Feb;47(1):53-8
pubmed: 16489697
Hum Immunol. 2006 Apr-May;67(4-5):247-56
pubmed: 16720204
Lancet. 1991 Jun 29;337(8757):1569-70
pubmed: 1675710
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Biochem Soc Trans. 2008 Dec;36(Pt 6):1461-6
pubmed: 19021576
Clin Oral Investig. 2011 Oct;15(5):699-704
pubmed: 20499118
J Oral Pathol Med. 2010 Nov;39(10):729-34
pubmed: 20923445
Immunology. 2011 Feb;132(2):296-305
pubmed: 21091907
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Dent Clin North Am. 2014 Apr;58(2):299-313
pubmed: 24655524
Med Oral Patol Oral Cir Bucal. 2015 Mar 01;20(2):e199-204
pubmed: 25681372
Clin Oral Investig. 2016 May;20(4):781-9
pubmed: 26303648
Biotech Histochem. 2016;91(4):237-41
pubmed: 26984382
J Dermatol Sci. 2016 Sep;83(3):244-7
pubmed: 27286581
BMC Oral Health. 2016 Aug 20;16(1):76
pubmed: 27544215
Acta Inform Med. 2016 Dec;24(6):390-393
pubmed: 28077900
Oral Dis. 2018 Apr;24(3):377-383
pubmed: 28741807
J Biol Chem. 1987 Jun 5;262(16):7451-4
pubmed: 3584121
Lancet. 1995 Oct 7;346(8980):941-3
pubmed: 7564730
Immunogenetics. 1994;40(1):37-44
pubmed: 8206524
Q J Med. 1993 Sep;86(9):575-82
pubmed: 8255972
Nature. 1997 Apr 3;386(6624):506-10
pubmed: 9087411